We worked with @CaPPRe_research to map patient treatment prefs, finding that characteristics of treatment (including the way that drugs are taken, the possibility of side effects, survival) are valued differently by different groups. Read for free here - h
New article: Myeloma Patient Value Mapping: A Discrete Choice Experiment on Myeloma Treatment Preferences in the UK. https://t.co/G6DVNoQnJY #MMSM #MultipleMyeloma #hematology https://t.co/G5YbxiP8GA
RT @Jaynegalinsky: This has been a v long time coming but our preference study has been published! This is a discrete choice experiment exa…
RT @Jaynegalinsky: This has been a v long time coming but our preference study has been published! This is a discrete choice experiment exa…
RT @Jaynegalinsky: This has been a v long time coming but our preference study has been published! This is a discrete choice experiment exa…
Our DCE found that different features of treatment (for example out of pocket costs, the way a treatment is administered, side effects) were important to different groups of patients. Thanks to all 475 patients who took part! https://t.co/J8ocruqyfO
RT @Jaynegalinsky: This has been a v long time coming but our preference study has been published! This is a discrete choice experiment exa…
This has been a v long time coming but our preference study has been published! This is a discrete choice experiment examining treatment preferences and risk benefit trade offs in decision making in myeloma treatment, with @simonfifer @CaPPRe_research htt